The goal of the Cancer Prevention, Outcomes & Survivorship (CPOS) program is to foster and facilitate research designed to identify and reduce cancer risk, and to improve cancer outcomes throughout the disease continuum. CPOS members represent a broad range of disciplines, including genetics, epidemiology, social and behavioral science, clinical oncology, biostatistics, health economics/services, and public health.
CPOS research studies are focused on three areas:
Chemoprevention scientists have continued their rigorous tests of hypothesis-driven investigator initiated trials which included intra- and inter-programmatic collaborations between clinical investigators, basic scientists, and quantitative researchers. This well-developed area of research continues to benefit from programmatic collaborations which have yielded national studies with translational endpoints. More recently, social and behavioral scientists have received support to examine factors associated with adolescent nicotine uptake, including marketing, social networks, and biomarker correlations to ADHD.
Inter-programmatic collaborations have, for example, led to discovery of a genetic panel which can predict treatment outcome for prostate cancer patients, and patient-reported data can predict mortality, poor function and hospitalizations in these patients. CPOS will continue to foster new collaborations to innovative approaches to evaluation of treatment type, costs, and decision-making as it affects cancer patients.
The CPOS interdisciplinary collaborative teams of clinical, behavioral and basic scientists have formed inter- and intra-programmatic collaborations to provide interventions for vulnerable cancer survivor populations. CPOS is working with new cancer center leadership to identify promising translational approaches which have relevance to our catchment area, and beyond.
In addition, CPOS continues to benefit from the robust chemoprevention and genetic epidemiology science legacies, while also experiencing an infusion of transdisciplinary collaborations created to improve cancer outcomes and survivorship. Taken together, CPOS improves the current knowledgebase and enhances cancer care within our community.
|De Alba, Israel|
|De Feraudy, Sebastien|
|Hubbell, F. Allan|